Latest Breaking News On - Ligand pharmaceuticals - Page 4 : comparemela.com

Perrigo Q1 Earnings Surpass, Sales Miss Estimates - Ligand Pharmaceuticals (NASDAQ:LGND), ANI Pharmaceuticals (NASDAQ:ANIP)

Perrigo Q1 Earnings Surpass, Sales Miss Estimates - Ligand Pharmaceuticals (NASDAQ:LGND), ANI Pharmaceuticals (NASDAQ:ANIP)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Roberto khouryWomen healthPerrigo companyLigand pharmaceuticalsChain reinvention programEarnings of ligand pharmaceuticalsConsumer self care internationalZacks consensus estimateSupply chain reinvention programConsumer self care americasSkin careSvend andersenExecutive vice presidentZacks rankStrong buyLigand pharmaceutical

Agenus (AGEN) Q1 2024 Earnings Call Transcript

Agenus (AGEN) Q1 2024 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

William blairChristine klaskinMatthew phippsMayank mamtanib rileyMayank mamtaniKelly shiGabriel kimEmily bodnarZack armenTodd yanceyGaro armenMatt phipps william blairRobin taylorLigand pharmaceuticalsCompany analystSteveno day

LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024

LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Ligand pharmaceuticals beatsLigand pharmaceuticalsMarket newsStock adviceBeats revenue

HC Wainwright Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)

HC Wainwright Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stephenl sabbaLigand pharmaceuticals incorporatedNews ratings for ligand pharmaceuticals dailyLigand pharmaceuticals tradingLigand pharmaceuticalsPacer advisors incChina universal asset management coDeutsche bankAllspring global investments holdingsImpax asset management groupGet free reportDirector stephenAsset management groupGlobal investments holdingsUniversal asset managementPharmaceuticals incorporated

Ligand Pharmaceuticals (NASDAQ:LGND) Posts Earnings Results, Beats Estimates By $3.01 EPS

Ligand Pharmaceuticals (NASDAQ:LGND) Posts Earnings Results, Beats Estimates By $3.01 EPS
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Stephenl sabbaLigand pharmaceuticals company profileLigand pharmaceuticals stockLigand pharmaceuticals incorporatedNews ratings for ligand pharmaceuticals dailyLigand pharmaceuticalsEarnings history for ligand pharmaceuticalsGet free reportDirector stephenPharmaceuticals incorporatedLigand pharmaceuticals daily